Blog
RSS FeedPosted by Michael Wonder on 12 Apr 2023
HTA reform starts today – consultations open
11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should ...
Posted by Michael Wonder on 11 Apr 2023
Health technology assessment policy and methods review consultation
11 April 2023 - The first round of public consultation for the HTA Review is open. Submissions will be accepted ...
Posted by Michael Wonder on 22 Mar 2023
HTA reform gets underway – terms of reference released today
22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
Posted by Michael Wonder on 22 Mar 2023
Terms of reference for the Health Technology Assessment Policy and Methods Review
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
Posted by Michael Wonder on 14 Mar 2023
CEO’s appointment to HTA Review Reference Committee
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...
Posted by Michael Wonder on 09 Mar 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (March 2023)
9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023. ...
Posted by Michael Wonder on 10 Feb 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (February 2023)
10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023. ...
Posted by Michael Wonder on 20 Jan 2023
Consultation on the revised PBS post-market review framework – publication of responses
20 January 2023 - Consultation on a revised draft of the PBS post-market review framework was open from 20 October ...
Posted by Michael Wonder on 18 Nov 2022
Medicines industry calls for discount rate reduction now
18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...
Posted by Michael Wonder on 27 Oct 2022
Health technology assessment review – frequently asked questions
27 October 2022 - The Department of Health & Aged Care has produced a two page summary on the upcoming ...
Posted by Michael Wonder on 27 Oct 2022
Independent chair of health technology assessment review will drive major reform of Australia’s health system
27 October 2022 - Medicines Australia welcomes the appointment of Adjunct Professor Debora Picone AO as independent Chair of the ...
Posted by Michael Wonder on 27 Oct 2022
Reference Committee for the health technology assessment policy and methods review
27 October 2022 - On 6 September 2021, the Commonwealth entered into a new Strategic Agreement in relation to reimbursement, ...
Posted by Michael Wonder on 27 Oct 2022
HTA review and chair committee
27 October 2022 - The Government today announced the appointment of Adjunct Professor Debora Picone AO as Chair of the Health ...
Posted by Michael Wonder on 26 Sep 2022
National Medicines Policy draft strides ahead but still room for improvement
26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...
Posted by Michael Wonder on 05 Sep 2022
Review of Efficient Funding of Chemotherapy Program - interim report
5 September 2022 - The Efficient Funding of Chemotherapy review seeks to investigate current processes involved in the production, distribution ...